Fusheng Wang, Academician of the Chinese Academy of Sciences, Chief Physician Professor Fusheng Wang is Academician of the Chinese Academy of Sciences, Chief Physician, Director of the Department of Infectious Diseases at the Fifth Medical Center of Chinese PLA General Hospital, and Director of the National Clinical Research Center for Infectious Diseases. He serves as an expert member of the Scientific Research Task Force under the Joint Prevention and Control Mechanism for COVID-19 of China, and was a delegate to the 19th National Congress of the Communist Party of China. He is also an expert of the Eighth Discipline Evaluation Group of the Academic Degrees Committee of the State Council and a member of the National and Military Biosafety Expert Group. Professor Wang has received numerous honors, including the National Innovation and Excellence Award, National Outstanding Science and Technology Worker Award, National Advanced Individual in Combating COVID-19, National Outstanding Communist Party Member Award, and recognition as a Leading Scientific and Technological Talent of the Chinese People's Liberation Army. He is a recipient of the National Science Fund for Distinguished Young Scholars, leader of a National Natural Science Foundation of China (NSFC) Innovative Research Group, and Chair-Elect of the Infectious Diseases Branch of the Chinese Medical Association.

Professor Wang has been dedicated to clinical practice, scientific research, and biosafety in infectious diseases for many years. He has played a key role in the clinical management of major public health emergencies, including the SARS outbreak in 2003, the prevention and control of H1N1 influenza in 2009, and the medical assistance mission for the Ebola outbreak in Sierra Leone in 2015. His research and clinical expertise focus on viral hepatitis, HIV/AIDS, and complex and critical liver diseases. By integrating clinical challenges with translational research, he has pioneered innovative approaches in cellular therapy and the treatment of challenging liver diseases and HIV/AIDS, contributing significantly to advances in infectious disease medicine.